Toth Financial Advisory Corp Sells 1,563 Shares of Colgate-Palmolive (NYSE:CL)

Toth Financial Advisory Corp cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,760 shares of the company’s stock after selling 1,563 shares during the period. Toth Financial Advisory Corp’s holdings in Colgate-Palmolive were worth $5,111,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Union Savings Bank raised its stake in shares of Colgate-Palmolive by 76.6% in the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares during the last quarter. Avion Wealth increased its position in shares of Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Core Wealth Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after buying an additional 146 shares during the last quarter. Finally, McGlone Suttner Wealth Management Inc. bought a new position in Colgate-Palmolive during the fourth quarter valued at about $34,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL traded down $1.13 during mid-day trading on Friday, reaching $97.04. 11,036,315 shares of the stock traded hands, compared to its average volume of 3,769,464. The company has a market cap of $79.62 billion, a price-to-earnings ratio of 30.69, a price-to-earnings-growth ratio of 3.61 and a beta of 0.39. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $99.08. The firm has a fifty day moving average price of $93.87 and a 200 day moving average price of $87.51. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm’s revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.73 earnings per share. As a group, equities research analysts predict that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 2.06%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Citigroup increased their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, April 16th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price for the company. Argus upped their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a research report on Wednesday, May 15th. Stifel Nicolaus lifted their price objective on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Finally, Evercore ISI upped their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $93.83.

Insiders Place Their Bets

In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.